These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 15297373)
1. AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells. Hwang JT; Lee M; Jung SN; Lee HJ; Kang I; Kim SS; Ha J Carcinogenesis; 2004 Dec; 25(12):2497-507. PubMed ID: 15297373 [TBL] [Abstract][Full Text] [Related]
2. Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma. Lee M; Hwang JT; Yun H; Kim EJ; Kim MJ; Kim SS; Ha J Biochem Pharmacol; 2006 Jun; 72(1):91-103. PubMed ID: 16678800 [TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Jung SN; Yang WK; Kim J; Kim HS; Kim EJ; Yun H; Park H; Kim SS; Choe W; Kang I; Ha J Carcinogenesis; 2008 Apr; 29(4):713-21. PubMed ID: 18258605 [TBL] [Abstract][Full Text] [Related]
5. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. Lee M; Hwang JT; Lee HJ; Jung SN; Kang I; Chi SG; Kim SS; Ha J J Biol Chem; 2003 Oct; 278(41):39653-61. PubMed ID: 12900407 [TBL] [Abstract][Full Text] [Related]
6. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. Gao N; Ding M; Zheng JZ; Zhang Z; Leonard SS; Liu KJ; Shi X; Jiang BH J Biol Chem; 2002 Aug; 277(35):31963-71. PubMed ID: 12070140 [TBL] [Abstract][Full Text] [Related]
7. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related]
8. 4-O-methylascochlorin, methylated derivative of ascochlorin, stabilizes HIF-1α via AMPK activation. Jeong JH; Kang JH; Hwang SL; Cho HJ; Park KK; Park YY; Chung IK; Chang HW; Kim CH; Min KS; Kim HD; Magae J; Kang SS; Chang YC Biochem Biophys Res Commun; 2011 Mar; 406(3):353-8. PubMed ID: 21329651 [TBL] [Abstract][Full Text] [Related]
10. 9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells. Fang J; Cao Z; Chen YC; Reed E; Jiang BH Mol Pharmacol; 2004 Jul; 66(1):178-86. PubMed ID: 15213310 [TBL] [Abstract][Full Text] [Related]
11. Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells. Tomita M; Semenza GL; Michiels C; Matsuda T; Uchihara JN; Okudaira T; Tanaka Y; Taira N; Ohshiro K; Mori N Biochem J; 2007 Sep; 406(2):317-23. PubMed ID: 17576198 [TBL] [Abstract][Full Text] [Related]
12. Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway. Jin HO; An S; Lee HC; Woo SH; Seo SK; Choe TB; Yoo DH; Lee SB; Um HD; Lee SJ; Park MJ; Kim JI; Hong SI; Rhee CH; Park IC Cell Signal; 2007 Jul; 19(7):1393-403. PubMed ID: 17307335 [TBL] [Abstract][Full Text] [Related]
14. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. García-Maceira P; Mateo J Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells. Zhong H; Hanrahan C; van der Poel H; Simons JW Biochem Biophys Res Commun; 2001 Jun; 284(2):352-6. PubMed ID: 11394885 [TBL] [Abstract][Full Text] [Related]
16. Activation of PI3K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells. Zhang Z; Yu D; Yin D; Wang Z Anim Reprod Sci; 2011 May; 125(1-4):42-8. PubMed ID: 21477953 [TBL] [Abstract][Full Text] [Related]
17. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873 [TBL] [Abstract][Full Text] [Related]
18. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. Yun H; Lee M; Kim SS; Ha J J Biol Chem; 2005 Mar; 280(11):9963-72. PubMed ID: 15640157 [TBL] [Abstract][Full Text] [Related]
19. Functional integrity of nuclear factor kappaB, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase signaling allows tumor necrosis factor alpha-evoked Bcl-2 expression to provoke internal ribosome entry site-dependent translation of hypoxia-inducible factor 1alpha. Zhou J; Callapina M; Goodall GJ; Brüne B Cancer Res; 2004 Dec; 64(24):9041-8. PubMed ID: 15604270 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Lu DY; Liou HC; Tang CH; Fu WM Biochem Pharmacol; 2006 Oct; 72(8):992-1000. PubMed ID: 16919605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]